Kaiser Permanente Redwood City Medical Center — Redwood City, California

Kaiser Permanente Redwood City Medical Center is a clinical research site located in Redwood City, California, United States 94063.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Kaiser Permanente Redwood City Medical Center has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma.

Sponsors: Celldex Therapeutics, Vascular Biogenics Ltd. operating as VBL Therapeutics, University of Cincinnati.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Redwood City

Browse all research sites in California · View every site in Redwood City

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente Redwood City Medical Center?

Kaiser Permanente Redwood City Medical Center has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente Redwood City Medical Center conducted?

Kaiser Permanente Redwood City Medical Center has 3 clinical trials on record, with 1 currently active. Their work covers Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma.

Is Kaiser Permanente Redwood City Medical Center accredited by Crixeo Clinical Trials?

Kaiser Permanente Redwood City Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kaiser Permanente Redwood City Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.